Cargando…
Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a very rare neoplasm, with distinct epidemiologic, morphologic and clinical characteristics. Molecular mechanistic insight into the pathogenesis of this carcinoma suggests a pivotal role for the host immune system in the proliferation and...
Autores principales: | Hermel, David J., Du, Emma Z., Lin, Ray, Frenette, Catherine T., Sigal, Darren S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111110/ https://www.ncbi.nlm.nih.gov/pubmed/34007809 http://dx.doi.org/10.14218/JCTH.2020.00094 |
Ejemplares similares
-
The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
por: Hermel, David J., et al.
Publicado: (2019) -
Lymphoepithelioma-Like Carcinoma of the Colon
por: Mori, Yasuharu, et al.
Publicado: (2013) -
Lymphoepithelioma-like carcinoma of the breast
por: Nankin, Nils L., et al.
Publicado: (2015) -
Lymphoepithelioma-like carcinoma of the skin
por: Oliveira, Cristiano Claudino, et al.
Publicado: (2018) -
Very Rare Liver Neoplasm: Lymphoepithelioma-Like (LEL) Hepatocellular Carcinoma
por: Filotico, Marcello, et al.
Publicado: (2018)